Latest Manufacturing News

Nanollose has successfully placed the $1.05 million shortfall from its recent entitlement offer, bolstering its capital to advance production and commercialisation of its innovative biomaterials.

Zoono Group has inked a five-year exclusive contract with Sharpak and OSY to apply its antimicrobial technology on UK soft fruit packaging, aiming to reduce food waste and boost shelf-life.

Atomo Diagnostics Limited has announced a capital raising initiative comprising a Share Purchase Plan (SPP) and a Placement, aiming to raise up to $1 million through the SPP and additional funds via a Placement, subject to shareholder approval at a June 23 meeting.

Green360 Technologies has successfully produced high-quality metakaolin from its kaolin resources, surpassing industry benchmarks and initiating commercial-scale trials with PERMAcast to validate its low-carbon cement formulations.

FFI Holdings Limited has announced a pro-rata non-renounceable entitlement offer priced at $3.50 per share, aiming to raise approximately $11 million to support its food manufacturing growth and property investments. The offer closes on 17 June 2025 and is open to eligible shareholders in Australia and New Zealand.

Clara Resources has launched a strategic review of its Kildanga polymetallic project following unsolicited interest, weighing options from divestment to joint ventures to enhance shareholder value.

RooLife Group Ltd (ASX:RLG) has secured its first $475,000 solar product order from India, marking a significant step in its global renewable energy expansion. This milestone underscores RLG’s unique model blending Chinese manufacturing with international marketing and distribution.

Archer Materials has teamed up with UK-based Paragraf to fast-track development of its Biochip sensor for at-home chronic kidney disease testing, aiming to enhance accuracy and product readiness over six months.

ITM Isotope Technologies Munich SE and Radiopharm Theranostics have entered a strategic supply agreement for the critical radioisotope Lutetium-177, underpinning Radiopharm’s clinical development of targeted cancer therapies.

Cynata Therapeutics confirms that the recent FDA orphan-drug exclusivity granted to Ryoncil® will not block approval of its CYP-001 therapy, highlighting key differences in drug composition and patient indications.

Simble Solutions Limited reported solid operational progress in 2024 and early 2025, highlighting new partnerships, product integrations, and a strategic push into renewable energy developments.

Larvotto Resources has announced an initial tungsten mineral resource at its Hillgrove Project, revealing a significant by-product opportunity alongside gold and antimony. This development could diversify revenue streams and enhance project economics amid rising tungsten prices.